This website uses cookies to improve your online experience. They are placed on your computer when you launched this website. You can change your cookie settings through your browser. If you continue to use this site, you consent to our use of cookies. Privacy Notice.

Walbrook home page
Register Your Interest

CelLBxHealth plc

Company Profile

Company website
https://cellbxhealth.com/
Sector
Pharmaceuticals and Biotechnology (Biotechnology)
Description
CelLBxHealth plc is a CTC intelligence company specializing in innovative circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology. Its patent-protected Parsortix® platform harvests CTCs from blood and can be integrated with existing laboratory instruments for comprehensive downstream analysis - including whole-cell imaging, proteomic profiling and full genomic workflows.

Latest Company
Presentation

Not all Walbrook clients have a handy 2 page summary available. Click on "Register your interest" and we'll let the Company know that you think this would be useful Investment_Summary

Latest Company Summary

Investor Access

22 Jun
Event information

Peter Collins, Chief Executive Officer, will provide an overview of the Company's preliminary results via the Investor Meet Company platform at 11:00 BST on Monday, 22 June 2026. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 09:00 BST the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet CelLBxHealth plc via: https://www.investormeetcompany.com/cellbxhealth-plc/register

Venue
Online
Time
Monday 22 June 2026 at 11:00 BST
Financial Calendar
 Event  Date
Year End 31 December
Half  Year End 30 June
Preliminary Results 22 June
Interim Results* September
AGM* June

* Months based on previous announcements of this kind

Latest Corporate Video

Latest News

Latest Tweets Twitter